Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis
EVERSANA, a leading provider of commercialization services to the life science industry, today announced a […]
Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer
Vividion Therapeutics, a biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets […]
GT Medical Technologies Raises $45 Million in Oversubscribed Series C Financing Led by Gilde Healthcare
GT Medical Technologies, a medical device company dedicated to improving the lives of patients with […]
Morphimmune Appoints Dr. Clay Siegall Chief Executive Officer and President
Morphimmune, a preclinical biotechnology company focused on developing targeted oncology therapeutics, today announced the appointment […]
Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care
Massive Bio, a private AI-enabled oncology startup that provides virtual and in-person concierge services for […]
Capstan Therapeutics Appoints Justin Thacker as Chief Financial Officer and Jeffrey Pepe, J.D., Ph.D., as General Counsel
Capstan Therapeutics, a biotechnology company dedicated to advancing in vivo reprogramming of cells through targeted […]
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Flare Therapeutics, a biotechnology company targeting transcription factors to discover precision medicines for cancer and […]
Ankyra Therapeutics Appoints Experienced Financial Executive Stephen Gorgol as Chief Financial Officer
Ankyra Therapeutics, a biotech company developing targeted immune-activating agents for the treatment of cancer, has […]
Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO
Semler Scientific, a company that provides technology solutions to improve the clinical effectiveness and efficiency […]
TaiGen Enters Exclusive License Agreement with Joincare for TG-1000 in China
TaiGen Biotechnology Company announces that they have signed an exclusive licensing agreement with Joincare Pharmaceutical […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more